SeeDNA co-precipitant from GE Healthcare, formerly Amersham Biosciences
EDTA, 0.5 M solution from GE Healthcare, formerly Amersham Biosciences
Mouse sTNF RII / TNFRSF1B from R&D Systems
Goat Anti-Mouse Wnt-11 Polyclonal Antibodies, from R&D Systems
Biology Products:(Date:11/24/2009)...ter of debate. A high-profile study a few years ag...ir carbon from trees and leaves, evidence for a ve...ecosystems. , But new research from the Universi...ue. Algae provide a much richer diet for fish and ...d this week in the Proceedings of the National Ac...
(Date:11/23/2009)...ciated strain of the deadly superbug MRSAan infect...bioticsposes a far greater health threat than prev... according to a study in the December issue of Em...s easily picked up in fitness centers, schools, an...l burden of MRSA within hospitals, the report foun...
(Date:11/23/2009)...icipants gathered this week for the seventh annual...ence. This year,s topic, "Synthetic Biology," brou...searchers to explore the engineering, scientific, ...f synthetic biology. , Bonnie L. Bassler, profes...nd this year,s conference chair, challenged the at...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Komen San Diego Ramps Up for Important Race for the Cure 28R 29 November 1 59157 1Komen San Diego Ramps Up for Important Race for the Cure 28R 29 November 1 59157 2Komen San Diego Ramps Up for Important Race for the Cure 28R 29 November 1 59157 3Komen San Diego Ramps Up for Important Race for the Cure 28R 29 November 1 59157 4Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 1Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 2Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 3Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 4Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz CA 5343 1Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz CA 5343 2(Date:11/24/2009)...eMarbleEnergyCorp.announcedtodaythatthecompanyandt...lyawarded$2millionbyWashingtonState,sCommunityEcon...nershiptoconstructthestate,sfirstspecialtybiochemi...tmentwillsignificantlyspeedthedevelopmentofourbior...dBlueMarbleEnergyCEOKellyOgilvie."Wearegratefultot...
(Date:11/24/2009)...etforpatientswithadvanced-stage,orrecurrentendomet...rstCall/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ...usedonendocrinetherapyandoncology,todayannouncedpo...ytotoxicpeptideconjugate,AEZS-108(formerlyAN-152),....Inapersonalizedhealthcareapproach,thestudyselecte...
(Date:11/24/2009)...rstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglo...edthatithassubmittedaMAAtotheEuropeanMedicinesAgen...enttherapyindevelopment,forthetreatmentofType1Gauc...elaglucerasealfathathasbeensubmitted,withprevious,...donaglobalsupplyshortageofthecurrentlyapprovedandm...
(Date:11/24/2009)...swire-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX ...tiveChairman,willpresentatthe21stAnnualPiperJaffra...er1,2009at10:00a.m.ET. ,, Toaccesstheliveandsub...InvestorRelationssectionofGenomicHealth,swebsiteat...othewebsiteatleast15minutespriortothebeginningofth...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2